Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Bouffet

Showing results (331-340 of 532) with videos related to

Pageof 54
Sort By:
Neuro-Oncology|January 12, 2022
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1Chelsea Kotch, Robert Avery, Kelly D Getz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2023
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade GliomaDarren R Hargrave, Keita Terashima, Junichi Hara, et al.
Frontiers in Oncology|October 14, 2024
BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited countryDima Abu Laban, Abeer Alsharif, Maysa Al-Hussaini, et al.
Pediatric Blood & Cancer|November 25, 2014
SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settingsJeannette Parkes, Marc Hendricks, Peter Ssenyonga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytomaCynthia Hawkins, Erin Walker, Nequesha Mohamed, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|April 30, 2017
Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experienceNisreen Amayiri, Maisa Swaidan, Yocoub Yousef, et al.
International Journal of Cancer|December 13, 2024
Birth characteristics and the risk of childhood brain tumors: A case-control study in Ontario, CanadaSierra Cheng, John R McLaughlin, M Catherine Brown, et al.
Journal of Neuro-Oncology|May 14, 2015
Low grade astrocytoma in children under the age of three years: a report from the Canadian pediatric brain tumour consortiumDonna L Johnston, Daniel Keene, Ute Bartels, et al.
Pediatric Blood & Cancer|August 29, 2025
Severe Hearing Loss in Children With Central Nervous System Tumors: A Population-Based Cancer in Young People in Canada (CYP-C) ReportHallie Coltin, Ofélie Trudeau-Ferrin, Sébastien Perreault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade gliomaEric Bouffet, Regina Jakacki, Stewart Goldman, et al.
Pageof 54

Showing results (331-340 of 532) with videos related to

Sort By:
Pageof 54
Neuro-Oncology|January 12, 2022
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1Chelsea Kotch, Robert Avery, Kelly D Getz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2023
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade GliomaDarren R Hargrave, Keita Terashima, Junichi Hara, et al.
Frontiers in Oncology|October 14, 2024
BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited countryDima Abu Laban, Abeer Alsharif, Maysa Al-Hussaini, et al.
Pediatric Blood & Cancer|November 25, 2014
SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settingsJeannette Parkes, Marc Hendricks, Peter Ssenyonga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytomaCynthia Hawkins, Erin Walker, Nequesha Mohamed, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|April 30, 2017
Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experienceNisreen Amayiri, Maisa Swaidan, Yocoub Yousef, et al.
International Journal of Cancer|December 13, 2024
Birth characteristics and the risk of childhood brain tumors: A case-control study in Ontario, CanadaSierra Cheng, John R McLaughlin, M Catherine Brown, et al.
Journal of Neuro-Oncology|May 14, 2015
Low grade astrocytoma in children under the age of three years: a report from the Canadian pediatric brain tumour consortiumDonna L Johnston, Daniel Keene, Ute Bartels, et al.
Pediatric Blood & Cancer|August 29, 2025
Severe Hearing Loss in Children With Central Nervous System Tumors: A Population-Based Cancer in Young People in Canada (CYP-C) ReportHallie Coltin, Ofélie Trudeau-Ferrin, Sébastien Perreault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade gliomaEric Bouffet, Regina Jakacki, Stewart Goldman, et al.
Pageof 54